Seqens supports emerging and large pharmaceutical customers, in human and animal health, with their small molecule early drug substance development needs through two main R&D locations in the regions of Boston and Paris

Our global R&D team in Porcheville, Paris, France and Newburyport, MA, USA, are experienced in providing API CMC (Chemistry, Manufacturing and Controls) requirements to meet your project needs, including:


SEQENS offers a wide range of services

Seqens supports emerging and large pharmaceutical customers, in human and animal health, with their small molecule early drug substance development needs through two main R&D locations[MM1]  in the regions of Boston and Paris.

Our global R&D team in Porcheville, Paris, France and Newburyport, MA, USA, are experienced in providing API CMC (Chemistry, Manufacturing and Controls) requirements to meet your project needs, including:

  • Route selection
  • Chemical process development including controlled substances
  • Large scale chromatography
  • Analytical development
  • EHS assessments
  • Solid state services including polymorphism evaluation
  • API clinical supply using cGMP kilo-lab suites or pilot plants
  • ICH stability studies

Our locations

Address 9 Opportunity Way
MA 01950 Newburyport
Business Line Custom Early Phase Pharmaceutical
Phone (978) 462 5555
Market Pharmaceutical
Mail derek.richards@seqens.com
More information

Surface: 5, 600 m²

Lab surface: 460 m²

Capabilities:

  • Process Research – Custom synthesis & synthetic route evlaution from g – kg for API’s or intermediates
  • Process Development – Custom synthesis from kg – metric tons
  • cGMP Small Molecule API Manufacturing (Phase 1, Phase 2, Phase 3, Commerical)
  • cGMP Medical Grade Polymers, Analytical Method Development

Flagship technologies: 

  • Controlled Substances
  • Cryogenic Chemistry -90°C
  • Lyophilization, Small/Large Scale Chromatography
  • Tangential Flow Filtration

Last inspection: July 2018 FDA Inspection

Address ZI de Limay 2, 8 Rue de Rouen
78440 Porcheville
Phone +33 1 34 79 57 00
Market Pharmaceutical, Specialty Ingredients & Cosmetics
Mail ContactSeqensPCV@seqens.com
More information

Surface: 40 000 m²

 

Lab surface: 2 000 m²

 

Capabilities:

  • 4 kilo-labs
  • 2 cGMP pilot plants with 11 multipurpose reactors from 100 L to 2 800 L (total capacity of 12 m³)
  • Temperature range: -15/+150°C  (hastelloy reactor: -80/+200°C)
  • 3 finishing rooms (agitated filter dryers, filters, dryers, milling and sieving equipments)

Flagship technologies:

  • Crystallization expertise and technologiesd(salt, co-crystal and polymorph screenings, process development)
  • Process Safety expertise and tecnologies
  • Flow chemistry for fine chemicals
  • Potent API process development
  • Genotoxic Impurities
  • Issue Management
  • Generic A.P.I Solid state expertis

Last inspection: ANSM  October 2018

Certification: cGMP

 

Number of scientists: 110

 

Other: Ecosystem Pharma with integrated services

 
Address 88 Jackson Road, Building 649
MA 01434 Devens
Business Line R&D center
Phone (978) 772 2111
Market Pharmaceutical
Mail Accueil@seqens.com
More information

Lab surface: 1 000 m²

Capabilities:

  • Controlled substances (Schedule II-V)
  • 5 Kilo-Labs

Number of scientists: 30